Vimentin 3, the New Hope, Differentiating RCC versus Oncocytoma

Vimentin is currently used to differentiate between malignant renal carcinomas and benign oncocytomas. Recent reports showing Vimentin positive oncocytomas seriously question the validity of this present diagnostic approach. Vimentin 3 is a spliced variant and ends with a unique C-terminal ending af...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Dis Markers
Main Authors: von Brandenstein, Melanie, Puetz, Katharina, Schlosser, Monika, Löser, Heike, Kallinowski, Joachim P., Gödde, Daniel, Buettner, Reinhard, Störkel, Stefan, Fries, Jochen W. U.
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Publishing Corporation 2015
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4405285/
https://ncbi.nlm.nih.gov/pubmed/25944973
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/368534
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados